Biogen Inc.
DE ˙ DB ˙ US09062X1037
170,90 € ↑8,70 (5,36%)
2026-06-04
AKTIENPREIS
SecurityDE:IDP / Biogen Inc.
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership27 shares
Latest Disclosed Value $ 4,950
Pinnacle Bancorp, Inc. ownership in IDP / Biogen Inc.

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 27 shares of Biogen Inc. (DE:IDP) valued at $4,192 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 27 shares of Biogen Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $4,614 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Biogen Idec Inc Com COM 09062X103 27 0 0.00 5 0.00 0.0015
2026-01-22 2025-12-31 13F Biogen Idec Inc Com COM 09062X103 27 -5 -15.62 5 0.00 0.0014
2025-10-24 2025-09-30 13F Biogen Idec Inc Com COM 09062X103 32 0 0.00 4 0.00 0.0013
2025-07-11 2025-06-30 13F Biogen Idec Inc Com COM 09062X103 32 9 39.13 4 33.33 0.0012
2025-04-23 2025-03-31 13F Biogen Idec Inc Com COM 09062X103 23 23 3 0.0010
2025-01-14 2024-12-31 13F Biogen Idec Inc Com COM 09062X103 0 -45 -100.00 0 -100.00
2024-10-09 2024-09-30 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 9 -20.00 0.0023
2024-07-15 2024-06-30 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 10 11.11 0.0031
2024-04-16 2024-03-31 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 10 -18.18 0.0029
2024-01-25 2023-12-31 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 12 0.00 0.0038
2023-10-18 2023-09-30 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 12 -8.33 0.0041
2023-07-14 2023-06-30 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 13 0.00 0.0044
2023-04-14 2023-03-31 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 13 0.0046
2023-01-24 2022-12-31 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 0 -100.00 0.0046
2022-10-25 2022-09-30 13F Biogen Idec Inc Com COM 09062X103 45 0 0.00 12 33.33 0.0052
2022-07-12 2022-06-30 13F Biogen Idec Inc Com COM 09062X103 45 -269 -85.67 9 -86.36 0.0037
2022-04-14 2022-03-31 13F Biogen Idec Inc Com COM 09062X103 314 -93 -22.85 66 -32.65 0.0229
2022-01-19 2021-12-31 13F Biogen Idec Inc Com COM 09062X103 407 -70 -14.68 98 -27.41 0.0346
2021-10-12 2021-09-30 13F Biogen Idec Inc Com COM 09062X103 477 -5 -1.04 135 -19.16 0.0540
2021-07-15 2021-06-30 13F Biogen Idec Inc Com COM 09062X103 482 -506 -51.21 167 -39.49 0.0762
2021-04-26 2021-03-31 13F Biogen Idec Inc Com COM 09062X103 988 -31 -3.04 276 10.40 0.1337
2021-01-13 2020-12-31 13F Biogen Idec Inc Com COM 09062X103 1,019 70 7.38 250 -7.06 0.1540
2020-10-13 2020-09-30 13F Biogen Idec Inc Com COM 09062X103 949 0 0.00 269 5.91 0.1896
2020-07-07 2020-06-30 13F Biogen Idec Inc Com COM 09062X103 949 10 1.06 254 -14.48 0.1889
2020-04-09 2020-03-31 13F Biogen Idec Inc Com COM 09062X103 939 0 0.00 297 6.45 0.2537
2020-01-10 2019-12-31 13F Biogen Idec Inc Com COM 09062X103 939 -106 -10.14 279 14.81 0.1933
2019-10-08 2019-09-30 13F Biogen Idec Inc Com COM 09062X103 1,045 -224 -17.65 243 -18.18 0.1387
2019-07-08 2019-06-30 13F Biogen Idec Inc Com COM 09062X103 1,269 25 2.01 297 1.02 0.1669
2019-04-05 2019-03-31 13F Biogen Idec Inc Com COM 09062X103 1,244 -59 -4.53 294 -25.00 0.1705
2019-03-20 2018-12-31 13F Biogen Idec Inc Com COM 09062X103 1,303 488 59.88 392 75.78 0.2411
2017-04-17 2017-03-31 13F Biogen Idec Inc Com COM 09062X103 815 815 223 0.1577
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.